AIDS case reporting: do we still need it?

The Lancet

Volumn 373, Issue 9658, 2009, Pages 181-183

  Kaldor, John M ^a   Delpech, Valerie ^b   Guy, Rebecca J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DIAGNOSTIC TEST; DISEASE COURSE; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 58149229336     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61006-5     Document Type: Note

References (26)

1. EuroHIV. European Centre for the Epidemiological Monitoring of HIV/AIDSWHO and UNAIDS Collaborating Centre on HIV/AIDS. HIV/AIDS Surveillance in Europe, Mid-year report 2006 No 74 (2007), French Institute for Public Health Surveillance, Saint-Maurice
2. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Report 2006: National Centre in HIV Epidemiology and Clinical Research, The University Of New South Wales (2006). http://www.nchecr.unsw.edu.au/NCHECRweb.nsf/page/Annual%20Surveillance%2 0Reports (accessed July 22, 2008).
3. Diaz T., Loth G., Whitworth J., and Sutherland D. Surveillance methods to monitor the impact of HIV therapy programmes in resource-constrained countries. AIDS 19 suppl 2 (2005) S31-S37
4. WHO Regional Office for Africa. HIV/AIDS Epidemiological Surveillance Report for the WHO African Region 2005 Update. http://www.who.int/hiv/pub/epidemiology/afroreport/en/index.html (accessed May 1, 2008).
5. Centers from Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 (1992) 1-19
6. Ancelle-Park R.A., Alix J., Downs A.M., and Brunet J.B. Impact of 1993 revision of adult/adolescent AIDS surveillance case-definition for Europe. National Coordinators for AIDS Surveillance in 38 European countries. Lancet 345 (1995) 789-790
7. Australian Government Department of Health and Ageing. Communicable Diseases Network Australia. Australian National Notifiable Diseases Case Definitions (2004). http://www.health.gov.au/internet/wcms/publishing.nsf/Content/cda_survei l-nndss-dislist.htm (accessed 27 June, 2006).
8. World Health Organization. WHO case definitions for AIDS surveillance in adults and adolescents. Wkly Epidemiol Rec 69 (1994) 273-280
9. Centers for Disease Control and Prevention. Current Trends Update on Acquired Immune Deficiency Syndrome (AIDS)-United States. MMWR Weekly 31 (1982) 507-514
10. Curran J.W., Lawrence D.N., Jaffe H., et al. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med 310 (1984) 69-75
11. Kegeles S.M., Catania J.A., Coates T.J., Pollack L.M., and Lo B. Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances. AIDS 4 (1990) 585-588
12. Forbes A. Mandatory name-based reporting: impact and alternatives. AIDS Policy Law (1996) 1-4
13. Monitoring the AIDS Pandemic Network (MAP). AIDS in Asia: face the facts-a comprehensive analysis of the AIDS epidemics in Asia (2004), Monitoring the AIDS Pandemic Network, Geneva. http://www.fhi.org/en/hivaids/pub/survreports/aids_in_asia.htm (accessed July 22, 2008).
14. Sladden T. Twenty years of HIV surveillance in the Pacific-what do the data tell us and what do we still need to know?. Pacific Health Dialog 12 (2005) 23-37
15. World Health Organization. Global AIDS surveillance-part I. Wkly Epidemiol Rec 72 (1997) 357-358
16. Centers for Disease Control and Prevention. HIV Prevalence Estimates and AIDS Case Projections for the United States: Report Based upon a Workshop-Appendix A. MMWR Wkly 39 (1990) 19-26
17. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994. Commun Dis Rep CDR Rev 6 (1996) R1-R21
18. Brookmeyer R., and Damiano A. Statistical methods for short-term projections of AIDS incidence. Stat Med 8 (1989) 23-34
19. The UK Collaborative Group for HIV and STI Surveillance. Testing Times - HIV and other Sexually Transmitted Infections in the United Kingdom: 2007 (2007), Health Protection Agency, Centre for Infections, London. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/12030843559 41 (accessed July 22, 2008).
20. World Health Organization. Progress on Global Access to HIV Antiretroviral treatment: An Update on "3 by 5" (2006), WHO, Geneva. http://www.who.int/hiv/fullreport_en_highres.pdf (accessed July 22, 2008).
21. The United States President's Emergency Plan for AIDS Relief. Bringing Hope: Supplying Antiretroviral Drugs for HIV/AIDS Treatment (2006), Office of the US Global AIDS Coordinator, Washington, DC. http://www.state.gov/documents/organization/66513.pdf (accessed July 22, 2008).
22. World Health Organization. Guidance on provider-initiated HIV testing and counselling in health facilities (2007), WHO, Geneva
23. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Vol 17. Rev ed Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention (2007). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/ (accessed July 22, 2008).
24. Brannstrom J., Akerlund B., Arneborn M., Blaxhult A., and Giesecke J. Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002-a remaining problem in the highly active antiretroviral therapy era. Int J STD AIDS 16 (2005) 702-706
25. McDonald A.M., Li Y., Dore G.J., Ree H., and Kaldor J.M. Late HIV presentation among AIDS cases in Australia, 1992-2001. Aust N Z J Public Health 27 (2003) 608-613
26. Law M., Friis-Moller N., Weber R., et al. Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study. HIV Med 4 (2003) 1-10